FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 360:189-190 January 8, 2009 Number 2 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Stanley, F. J. Related Article by Rouse, D. J. PubMed Citation

To the Editor: In their article on the use of magnesium sulfate before preterm birth to prevent cerebral palsy, Rouse et al. (Aug. 28 issue)¹ refer to a study, the Magnesium and Neurologic Endpoints Trial (MagNET), a cerebral-palsy prevention study we helped to design and analyze in collaboration with the National Institutes of Health.² Although complaints about MagNET (e.g., the use of twins data and low mortality among control subjects) were cited by Rouse et al. in the Discussion section, our reply was not acknowledged.³ Of importance, MagNET's finding of excess pediatric mortality after tocolytic use of magnesium sulfate was . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.